Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

IRIX vs DBVT vs ALKS vs LASE

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
IRIX
IRIDEX Corporation

Medical - Devices

HealthcareNASDAQ • US
Market Cap$18M
5Y Perf.-57.3%
DBVT
DBV Technologies S.A.

Biotechnology

HealthcareNASDAQ • FR
Market Cap$1690.08T
5Y Perf.+11.5%
ALKS
Alkermes plc

Biotechnology

HealthcareNASDAQ • IE
Market Cap$5.83B
5Y Perf.+56.7%
LASE
Laser Photonics Corporation

Industrial - Machinery

IndustrialsNASDAQ • US
Market Cap$19M
5Y Perf.-66.2%

IRIX vs DBVT vs ALKS vs LASE — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
IRIX logoIRIX
DBVT logoDBVT
ALKS logoALKS
LASE logoLASE
IndustryMedical - DevicesBiotechnologyBiotechnologyIndustrial - Machinery
Market Cap$18M$1690.08T$5.83B$19M
Revenue (TTM)$51M$0.00$1.56B$7M
Net Income (TTM)$-5M$-168M$153M$-8M
Gross Margin38.0%65.4%31.1%
Operating Margin-6.0%12.3%-126.5%
Forward P/E24.5x
Total Debt$5M$22M$70M$5M
Cash & Equiv.$2M$194M$1.12B$534K

IRIX vs DBVT vs ALKS vs LASELong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

IRIX
DBVT
ALKS
LASE
StockSep 22May 26Return
IRIDEX Corporation (IRIX)10042.7-57.3%
DBV Technologies S.… (DBVT)100111.5+11.5%
Alkermes plc (ALKS)100156.7+56.7%
Laser Photonics Cor… (LASE)10033.8-66.2%

Price return only. Dividends and distributions are not included.

Quick Verdict: IRIX vs DBVT vs ALKS vs LASE

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: ALKS leads in 4 of 6 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. DBV Technologies S.A. is the stronger pick specifically for recent price momentum and sentiment. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
IRIX
IRIDEX Corporation
The Specific-Use Pick

IRIX plays a supporting role in this comparison — it may shine differently against other peers.

Best for: healthcare exposure
DBVT
DBV Technologies S.A.
The Momentum Pick

DBVT is the #2 pick in this set and the best alternative if momentum is your priority.

  • +100.5% vs LASE's -69.6%
Best for: momentum
ALKS
Alkermes plc
The Income Pick

ALKS carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • Dividend streak 0 yrs, beta 1.00
  • Rev growth -5.2%, EPS growth -34.1%, 3Y rev CAGR 9.9%
  • -12.0% 10Y total return vs LASE's -66.2%
  • Lower volatility, beta 1.00, Low D/E 3.8%, current ratio 3.55x
Best for: income & stability and growth exposure
LASE
Laser Photonics Corporation
The Secondary Option

LASE lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: industrials exposure
See the full category breakdown
CategoryWinnerWhy
GrowthALKS logoALKS-5.2% revenue growth vs DBVT's -100.0%
Quality / MarginsALKS logoALKS9.8% margin vs LASE's -105.4%
Stability / SafetyALKS logoALKSBeta 1.00 vs LASE's 1.81, lower leverage
DividendsTieNone of these 4 stocks pay a meaningful dividend
Momentum (1Y)DBVT logoDBVT+100.5% vs LASE's -69.6%
Efficiency (ROA)ALKS logoALKS5.4% ROA vs DBVT's -89.0%

IRIX vs DBVT vs ALKS vs LASE — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

IRIXIRIDEX Corporation
FY 2024
Retina
57.2%$28M
Cyclo G Six
26.1%$13M
Product and Service, Other
16.7%$8M
DBVTDBV Technologies S.A.

Segment breakdown not available.

ALKSAlkermes plc
FY 2025
Vivitrol
39.8%$468M
Aristada And Aristada Initio
31.5%$370M
Manufactured Product And Royalty
24.8%$291M
Manufacturing Revenue
3.9%$46M
LASELaser Photonics Corporation

Segment breakdown not available.

IRIX vs DBVT vs ALKS vs LASE — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLALKSLAGGINGDBVT

Income & Cash Flow (Last 12 Months)

ALKS leads this category, winning 4 of 6 comparable metrics.

ALKS and DBVT operate at a comparable scale, with $1.6B and $0 in trailing revenue. ALKS is the more profitable business, keeping 9.8% of every revenue dollar as net income compared to LASE's -105.4%. On growth, LASE holds the edge at +28.3% YoY revenue growth, suggesting stronger near-term business momentum.

MetricIRIX logoIRIXIRIDEX CorporationDBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcLASE logoLASELaser Photonics C…
RevenueTrailing 12 months$51M$0$1.6B$7M
EBITDAEarnings before interest/tax-$2M-$112M$212M-$8M
Net IncomeAfter-tax profit-$5M-$168M$153M-$8M
Free Cash FlowCash after capex-$3M-$151M$392M-$4M
Gross MarginGross profit ÷ Revenue+38.0%+65.4%+31.1%
Operating MarginEBIT ÷ Revenue-6.0%+12.3%-126.5%
Net MarginNet income ÷ Revenue-10.0%+9.8%-105.4%
FCF MarginFCF ÷ Revenue-5.6%+25.1%-58.7%
Rev. Growth (YoY)Latest quarter vs prior year+7.8%+28.2%+28.3%
EPS Growth (YoY)Latest quarter vs prior year+25.0%+91.5%-4.1%-7.4%
ALKS leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

Evenly matched — IRIX and DBVT and LASE each lead in 1 of 3 comparable metrics.
MetricIRIX logoIRIXIRIDEX CorporationDBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcLASE logoLASELaser Photonics C…
Market CapShares × price$18M$1690.08T$5.8B$19M
Enterprise ValueMkt cap + debt − cash$20M$1690.08T$4.8B$24M
Trailing P/EPrice ÷ TTM EPS-1.91x-0.75x24.47x-3.97x
Forward P/EPrice ÷ next-FY EPS est.
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple17.01x
Price / SalesMarket cap ÷ Revenue0.36x3.95x5.68x
Price / BookPrice ÷ Book value/share8.07x0.65x3.25x1.08x
Price / FCFMarket cap ÷ FCF12.14x
Evenly matched — IRIX and DBVT and LASE each lead in 1 of 3 comparable metrics.

Profitability & Efficiency

ALKS leads this category, winning 8 of 9 comparable metrics.

ALKS delivers a 8.8% return on equity — every $100 of shareholder capital generates $9 in annual profit, vs $-184 for LASE. ALKS carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to IRIX's 2.21x. On the Piotroski fundamental quality scale (0–9), ALKS scores 7/9 vs LASE's 1/9, reflecting strong financial health.

MetricIRIX logoIRIXIRIDEX CorporationDBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcLASE logoLASELaser Photonics C…
ROE (TTM)Return on equity-108.7%-130.2%+8.8%-183.5%
ROA (TTM)Return on assets-17.9%-89.0%+5.4%-43.1%
ROICReturn on invested capital-129.9%+18.9%-42.1%
ROCEReturn on capital employed-48.8%-145.7%+14.2%-45.9%
Piotroski ScoreFundamental quality 0–92471
Debt / EquityFinancial leverage2.21x0.13x0.04x0.49x
Net DebtTotal debt minus cash$2M-$172M-$1.0B$4M
Cash & Equiv.Liquid assets$2M$194M$1.1B$533,871
Total DebtShort + long-term debt$5M$22M$70M$5M
Interest CoverageEBIT ÷ Interest expense-189.82x32.30x-6.60x
ALKS leads this category, winning 8 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

Evenly matched — DBVT and ALKS each lead in 3 of 6 comparable metrics.

A $10,000 investment in ALKS five years ago would be worth $16,165 today (with dividends reinvested), compared to $1,377 for IRIX. Over the past 12 months, DBVT leads with a +100.5% total return vs LASE's -69.6%. The 3-year compound annual growth rate (CAGR) favors DBVT at 5.7% vs LASE's -34.4% — a key indicator of consistent wealth creation.

MetricIRIX logoIRIXIRIDEX CorporationDBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcLASE logoLASELaser Photonics C…
YTD ReturnYear-to-date-12.0%+3.6%+23.8%-56.3%
1-Year ReturnPast 12 months-9.6%+100.5%+15.2%-69.6%
3-Year ReturnCumulative with dividends-54.6%+18.1%+13.2%-71.7%
5-Year ReturnCumulative with dividends-86.2%-68.3%+61.7%-66.2%
10-Year ReturnCumulative with dividends-90.8%-87.1%-12.0%-66.2%
CAGR (3Y)Annualised 3-year return-23.2%+5.7%+4.2%-34.4%
Evenly matched — DBVT and ALKS each lead in 3 of 6 comparable metrics.

Risk & Volatility

ALKS leads this category, winning 2 of 2 comparable metrics.

ALKS is the less volatile stock with a 1.00 beta — it tends to amplify market swings less than LASE's 1.81 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ALKS currently trades 95.6% from its 52-week high vs LASE's 12.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricIRIX logoIRIXIRIDEX CorporationDBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcLASE logoLASELaser Photonics C…
Beta (5Y)Sensitivity to S&P 5001.16x1.26x1.00x1.81x
52-Week HighHighest price in past year$1.65$26.18$36.60$6.77
52-Week LowLowest price in past year$0.87$7.53$25.17$0.38
% of 52W HighCurrent price vs 52-week peak+62.4%+75.3%+95.6%+12.9%
RSI (14)Momentum oscillator 0–10041.647.460.537.5
Avg Volume (50D)Average daily shares traded124K252K2.2M1.9M
ALKS leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

LASE leads this category, winning 1 of 1 comparable metric.

Analyst consensus: DBVT as "Buy", ALKS as "Buy". Consensus price targets imply 134.8% upside for DBVT (target: $46) vs 31.5% for ALKS (target: $46).

MetricIRIX logoIRIXIRIDEX CorporationDBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcLASE logoLASELaser Photonics C…
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$46.33$46.00
# AnalystsCovering analysts1528
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises002
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%+0.5%0.0%
LASE leads this category, winning 1 of 1 comparable metric.
Key Takeaway

ALKS leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). LASE leads in 1 (Analyst Outlook). 2 tied.

Best OverallAlkermes plc (ALKS)Leads 3 of 6 categories
Loading custom metrics...

IRIX vs DBVT vs ALKS vs LASE: Key Questions Answered

8 questions · data-driven answers · updated daily

01

Is IRIX or DBVT or ALKS or LASE a better buy right now?

For growth investors, Alkermes plc (ALKS) is the stronger pick with -5.

2% revenue growth year-over-year, versus -13. 3% for Laser Photonics Corporation (LASE). Alkermes plc (ALKS) offers the better valuation at 24. 5x trailing P/E, making it the more compelling value choice. Analysts rate DBV Technologies S. A. (DBVT) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — IRIX or DBVT or ALKS or LASE?

Over the past 5 years, Alkermes plc (ALKS) delivered a total return of +61.

7%, compared to -86. 2% for IRIDEX Corporation (IRIX). Over 10 years, the gap is even starker: ALKS returned -12. 0% versus IRIX's -90. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — IRIX or DBVT or ALKS or LASE?

By beta (market sensitivity over 5 years), Alkermes plc (ALKS) is the lower-risk stock at 1.

00β versus Laser Photonics Corporation's 1. 81β — meaning LASE is approximately 82% more volatile than ALKS relative to the S&P 500. On balance sheet safety, Alkermes plc (ALKS) carries a lower debt/equity ratio of 4% versus 2% for IRIDEX Corporation — giving it more financial flexibility in a downturn.

04

Which is growing faster — IRIX or DBVT or ALKS or LASE?

By revenue growth (latest reported year), Alkermes plc (ALKS) is pulling ahead at -5.

2% versus -13. 3% for Laser Photonics Corporation (LASE). On earnings-per-share growth, the picture is similar: Laser Photonics Corporation grew EPS 40. 5% year-over-year, compared to -347. 5% for DBV Technologies S. A.. Over a 3-year CAGR, ALKS leads at 9. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — IRIX or DBVT or ALKS or LASE?

Alkermes plc (ALKS) is the more profitable company, earning 16.

4% net margin versus -73. 8% for Laser Photonics Corporation — meaning it keeps 16. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ALKS leads at 17. 2% versus -189. 3% for LASE. At the gross margin level — before operating expenses — ALKS leads at 86. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Which pays a better dividend — IRIX or DBVT or ALKS or LASE?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

07

Is IRIX or DBVT or ALKS or LASE better for a retirement portfolio?

For long-horizon retirement investors, Alkermes plc (ALKS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.

00)). Laser Photonics Corporation (LASE) carries a higher beta of 1. 81 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ALKS: -12. 0%, LASE: -66. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

08

What are the main differences between IRIX and DBVT and ALKS and LASE?

These companies operate in different sectors (IRIX (Healthcare) and DBVT (Healthcare) and ALKS (Healthcare) and LASE (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

IRIX

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Gross Margin > 22%
Run This Screen
Stocks Like

DBVT

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Stocks Like

ALKS

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 14%
  • Net Margin > 5%
Run This Screen
Stocks Like

LASE

High-Growth Disruptor

  • Sector: Industrials
  • Market Cap > $100B
  • Revenue Growth > 14%
  • Gross Margin > 18%
Run This Screen

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.